Close

Rating History for Corcept Therapeutics (CORT) by Canaccord Genuity

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/27/2022 Edward Nash New Coverage Buy
(N/A)
34.00
(N/A)
23.80
(24.35)
2.31% Details